On optimal treatment regimes selection for mean survival time

Yuan Geng, Hao Zhang, Wenbin Lu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In clinical studies with time-to-event as a primary endpoint, one main interest is to find the best treatment strategy to maximize patients' mean survival time. Due to patient's heterogeneity in response to treatments, great efforts have been devoted to developing optimal treatment regimes by integrating individuals' clinical and genetic information. A main challenge arises in the selection of important variables that can help to build reliable and interpretable optimal treatment regimes as the dimension of predictors may be high. In this paper, we propose a robust loss-based estimation framework that can be easily coupled with shrinkage penalties for both estimation of optimal treatment regimes and variable selection. The asymptotic properties of the proposed estimators are studied. Moreover, a model-free estimator of restricted mean survival time under the derived optimal treatment regime is developed, and its asymptotic property is studied. Simulations are conducted to assess the empirical performance of the proposed method for parameter estimation, variable selection, and optimal treatment decision. An application to an AIDS clinical trial data set is given to illustrate the method.

Original languageEnglish (US)
Pages (from-to)1169-1184
Number of pages16
JournalStatistics in Medicine
Volume34
Issue number7
DOIs
StatePublished - Mar 30 2015

Fingerprint

Survival Time
Survival Rate
Variable Selection
Therapeutics
Asymptotic Properties
Estimator
Selection of Variables
Shrinkage
Clinical Trials
Penalty
Parameter Estimation
Predictors
Acquired Immunodeficiency Syndrome
Maximise
Simulation

Keywords

  • adaptive LASSO
  • censored regression
  • mean survival time
  • optimal treatment regime
  • variable selection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

On optimal treatment regimes selection for mean survival time. / Geng, Yuan; Zhang, Hao; Lu, Wenbin.

In: Statistics in Medicine, Vol. 34, No. 7, 30.03.2015, p. 1169-1184.

Research output: Contribution to journalArticle

Geng, Yuan ; Zhang, Hao ; Lu, Wenbin. / On optimal treatment regimes selection for mean survival time. In: Statistics in Medicine. 2015 ; Vol. 34, No. 7. pp. 1169-1184.
@article{3022c462ebb04de2a1afea8cf5063fc2,
title = "On optimal treatment regimes selection for mean survival time",
abstract = "In clinical studies with time-to-event as a primary endpoint, one main interest is to find the best treatment strategy to maximize patients' mean survival time. Due to patient's heterogeneity in response to treatments, great efforts have been devoted to developing optimal treatment regimes by integrating individuals' clinical and genetic information. A main challenge arises in the selection of important variables that can help to build reliable and interpretable optimal treatment regimes as the dimension of predictors may be high. In this paper, we propose a robust loss-based estimation framework that can be easily coupled with shrinkage penalties for both estimation of optimal treatment regimes and variable selection. The asymptotic properties of the proposed estimators are studied. Moreover, a model-free estimator of restricted mean survival time under the derived optimal treatment regime is developed, and its asymptotic property is studied. Simulations are conducted to assess the empirical performance of the proposed method for parameter estimation, variable selection, and optimal treatment decision. An application to an AIDS clinical trial data set is given to illustrate the method.",
keywords = "adaptive LASSO, censored regression, mean survival time, optimal treatment regime, variable selection",
author = "Yuan Geng and Hao Zhang and Wenbin Lu",
year = "2015",
month = "3",
day = "30",
doi = "10.1002/sim.6397",
language = "English (US)",
volume = "34",
pages = "1169--1184",
journal = "Statistics in Medicine",
issn = "0277-6715",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - On optimal treatment regimes selection for mean survival time

AU - Geng, Yuan

AU - Zhang, Hao

AU - Lu, Wenbin

PY - 2015/3/30

Y1 - 2015/3/30

N2 - In clinical studies with time-to-event as a primary endpoint, one main interest is to find the best treatment strategy to maximize patients' mean survival time. Due to patient's heterogeneity in response to treatments, great efforts have been devoted to developing optimal treatment regimes by integrating individuals' clinical and genetic information. A main challenge arises in the selection of important variables that can help to build reliable and interpretable optimal treatment regimes as the dimension of predictors may be high. In this paper, we propose a robust loss-based estimation framework that can be easily coupled with shrinkage penalties for both estimation of optimal treatment regimes and variable selection. The asymptotic properties of the proposed estimators are studied. Moreover, a model-free estimator of restricted mean survival time under the derived optimal treatment regime is developed, and its asymptotic property is studied. Simulations are conducted to assess the empirical performance of the proposed method for parameter estimation, variable selection, and optimal treatment decision. An application to an AIDS clinical trial data set is given to illustrate the method.

AB - In clinical studies with time-to-event as a primary endpoint, one main interest is to find the best treatment strategy to maximize patients' mean survival time. Due to patient's heterogeneity in response to treatments, great efforts have been devoted to developing optimal treatment regimes by integrating individuals' clinical and genetic information. A main challenge arises in the selection of important variables that can help to build reliable and interpretable optimal treatment regimes as the dimension of predictors may be high. In this paper, we propose a robust loss-based estimation framework that can be easily coupled with shrinkage penalties for both estimation of optimal treatment regimes and variable selection. The asymptotic properties of the proposed estimators are studied. Moreover, a model-free estimator of restricted mean survival time under the derived optimal treatment regime is developed, and its asymptotic property is studied. Simulations are conducted to assess the empirical performance of the proposed method for parameter estimation, variable selection, and optimal treatment decision. An application to an AIDS clinical trial data set is given to illustrate the method.

KW - adaptive LASSO

KW - censored regression

KW - mean survival time

KW - optimal treatment regime

KW - variable selection

UR - http://www.scopus.com/inward/record.url?scp=84965087280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965087280&partnerID=8YFLogxK

U2 - 10.1002/sim.6397

DO - 10.1002/sim.6397

M3 - Article

C2 - 25515005

AN - SCOPUS:84919968650

VL - 34

SP - 1169

EP - 1184

JO - Statistics in Medicine

JF - Statistics in Medicine

SN - 0277-6715

IS - 7

ER -